Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-856-5 | CAS number: 111-30-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Remarks:
- Type of genotoxicity: DNA damage and/or repair
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 486 (Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- unscheduled DNA synthesis
Test material
- Reference substance name:
- Glutaral
- EC Number:
- 203-856-5
- EC Name:
- Glutaral
- Cas Number:
- 111-30-8
- Molecular formula:
- C5H8O2
- IUPAC Name:
- glutaraldehyde
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Physical state: homogeneous colourless-clear liquid
- Analytical purity: 50.5%
- Impurities (identity and concentrations): no data
- Composition of test material, percentage of components: ca. 50% glutaraldehyde in water
- Lot/batch No.: 50-4402
- Storage condition of test material: refrigerator (under N2 conditions)
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH
- Age at study initiation: about 10 to 12 weeks
- Weight at study initiation: about 256 g
- Assigned to test groups randomly: yes
- Housing: individually in Makrolon cages, type III
- Diet (e.g. ad libitum): standardized pelleted feed (Kliba-Haltungsdiät/Provimi Kliba SA, Kaiseraugst, Switzerland) , ad libitum
- Water (e.g. ad libitum): drinking water from bottles, ad libitum
- Acclimation period: not specified
- Other: feed, water and bedding were analyzed for contaminants.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24°C
- Humidity (%): 30 - 70%
- Air changes (per hr): fully air-conditioned rooms
- Photoperiod (hrs dark / hrs light): 12 hrs/ 12 hrs
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- purified water
- Details on exposure:
- PREPARATION OF THE TEST SOLUTIONS
All test solutions were prepared once weekly before administration. The amount of test material or volume to be administered was related to the specific weight of the individual animals on the day of treatment.
PRE TEST FOR DETERMINATION OF THE MTD
In a pretest for the determination of the acute oral toxicity (male and female rats), deaths were observed down to a dose of 400 mg/kg body weight (1 out of 14 animals were found dead the day after test substance administration). The clinical signs observed were piloerection, squatting posture, gasping respiration and bloody snout and the general state of the animals was poor. However, there were no distinct symptomatic differences between the male and female animals. Thus, only male animals were used for the main experiment.
Therefore, a dose of 400 mg/kg body weight was selected as the maximal tolerated dose level (MTD) for the main assay, and 200 mg/kg body weight were administered as further dose; both dosages refer to the aqueous test substance and not to the active ingredient, i.e.
Glutaraldehyde (about 50%).
UDS TEST
The test series consisted of following groups:
Control group 1 and 2: vehicle controls with animals receiving 10 mL water/kg bw.
Test groups 3 and 4: animals receiving 200 mg test substance/kg bw, application volume 10 mL/kg bw of a 2% test solution.
Test groups 5 and 6: animals receiving 400 mg test substance/kg bw, application volume 10 mL/kg bw of a 4% test solution.
All the animals were treated once and were examined for clinical signs of toxicity and body weight change.
The animals were sacrificed and their livers perfused 3 hours and 14 hours after treatment. - Duration of treatment / exposure:
- Not applicable as single application by gavage
- Frequency of treatment:
- Single application
- Post exposure period:
- 3 and 14 hrs after single dose administration
Doses / concentrationsopen allclose all
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Remarks:
- the test concentrations refer the test substance as such and not to the active ingredient
- Dose / conc.:
- 400 mg/kg bw/day (nominal)
- Remarks:
- the test concentrations refer the test substance as such and not to the active ingredient
- No. of animals per sex per dose:
- 3 animals were used per group.
- Control animals:
- yes
- Positive control(s):
- As a positive control, 50 mg of 2-acetylaminofluorene/kg bw, suspended in corn oil, was administered to the animals once orally in a volume of 10 mL/kg body weight.
The stability of 2-AAF is well-defined under the selected culture conditions, since 2-AAF is a well-established UDS-inducing agent.
Examinations
- Tissues and cell types examined:
- The hepatocytes were isolated from the liver of the treated animals 3 and 14 hours after treatment according to the procedure described by Butterworth BE et al., Mutat. Res. 189(2): 123-133, 1987). The main steps were as follows:
- Anesthetization of the animals with Metofane by inhalation;
- Liver perfusion with ethylene glycoI-bis(ß-amino ethyl ether) N,N,N',N',-tetraacetic acid (EGTA) solution followed by collagenase solution;
- Obtention of a cell suspension;
- Filtration, centrifugation steps with removal of supernatant and obtention of cell pellets;
- Resuspension of the cell pellets to yield single ceIl suspensions.
The hepatocytes were examined for cell viability as measured by the trypan blue exclusion technique, and for conspicuous changes in cell morphology.
DNA damage and repair was measured by incorporation of 3H-Thymidine using autoradiography technique. For this purpose about 400,000 viable cellson coverslips were seeded per well and 6 wells per animal were used for the UDS assay. For labeling, the initial medium was replaced by labeling medium, and the cells were incubated for 4 hours. The cells on the coverslips were then fixed, rinsed and air-dried before being mounted cell side up an glass slides using Corbit-Balsam.
Autoradiography was carried out according to the procedure of Butterworth et al. (see above), and for this purpose the slides were coated with KODAK NTB-2 photographic emulsion.
about 5 -10 seconds.
In fact, for microscopical evaluation and quantification of UDS, a total of 100 cells/animal was examined.
Following parameters were considered:
- the net nuclear grain (NNG) count/cell,
- the mean nuclear grain (NG) count,
- the mean cytoplasmic grain count (CG) count,
- the mean net nuclear grain count,
- the % of cells in repair (cells with NNG >= 0; cells with NNG >= 5). - Evaluation criteria:
- Acceptance criteria:
-Clearly negative results in the untreated and in the vehicle controls in the range of historical control data.
-Clearly positive results in the positive control group (>=30% of cells in repair, as mean of 3 animals) in the range of historical control data.
-Viability (trypan blue staining) of at least 70% in hepatocytes from negative control animals.
Evaluation criteria:
-Positive response: a positive response implicates a dose-related increase in mean number of NNG counts (> 0 at one of the test points) and in percentage of cells in repair (i.e. cells with NNG >= 5), which must be >= 20.
-Marginal response: a response is considered marginal when the dose-related increase in percentage of cells in repair is >= 5 outside the values of both the concurrent negative control and the historical control (>= 5 < 20), and when the dose-related increase in mean number of NNG counts is near to but without exceeding 0. In this case, an additional confirmatory test is needed.
-Negative response: a negative response implicates that both, the NNG counts and the percentage of cells in repair are within the range of negative control. - Statistics:
- Due to clear negative findings, a statistical evaluation was not carried out.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- The microscopical evaluation and quantification of UDS showed that the results obtained for the GA-treated animals were within the range of negative controls, as can be seen from the table included below.
- Toxicity:
- yes
- Remarks:
- Evident signs of toxicity were seen in animals treated with the test material at both test doses and included piloerection, squatting posture and bloody snout.
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- For all treated animals including those serving for positive control, the cell viability after 3 and 14 hours was within 94 - 102% of control.
The microscopical evaluation and quantification of UDS showed that for the negative controls, the frequencies of mean nuclear grain counts were within historical control range.
For the positive controls, the increase in unscheduled DNA synthesis was as expected.
The results obtained for the glutaraldehyde-treated animals were within the range of negative controls, as can be seen from following table.
Any other information on results incl. tables
Test group |
Negative Control. |
Protectol GDA 200 mg/kg bw |
Protectol GDA 400 mg/kg bw |
Positive control |
Cells harvested after 3 hours following treatment |
||||
NG counts* |
6.79 +/- 0.99 |
7.79 +/- 1.26 |
6.47 +/- 0.27 |
21.23 +/- 1.82 |
CG counts* |
12.07 +/- 1.46 |
14.61 +/- 0.26 |
12.45 +/- 0.19 |
15.46 +/- 1.40 |
NNG counts** |
- 5.28 +/- 0.65 |
- 6.82 +/- 1.02 |
-5.98 +/- 0.42 |
5.77 +/- 2.57 |
% cells in repair (NNG >= 0) |
8.33 +/- 0.58 |
6.00 +/- 3.61 |
3.33 +/- 1.53 |
80.33 +/- 9.07 |
% cells in repair (NNG >= 5) |
0.00 +/- 0.00 |
0.00 +/- 0.00 |
0.00 +/- 0.00 |
50.67 +/- 14.98 |
Cells harvested after 14 hours following treatment |
||||
NG counts* |
7.88 +/- 2.31 |
7.66 +/- 0.43 |
6.48 +/- 0.64 |
19.82 +/- 2.38 |
CG counts* |
13.01 +/- 2.70 |
13.67 +/- 1.17 |
11.57 +/- 1.36 |
13.63 +/- 1.62 |
NNG counts** |
-5.13 +/- 0.61 |
-6.01 +/- 0.76 |
-5.09 +/- 0.72 |
6.20 +/- 1.04 |
% cells in repair (NNG >= 0) |
8.33 +/- 0.58 |
6.33 +/- 4.51 |
6.33 +/- 2.08 |
80.00 +/- 3.61 |
% cells in repair (NNG >= 5) |
0.00 +/- 0.00 |
0.00 +/- 0.00 |
0.00 +/- 0.00 |
52.33 +/- 4.73 |
NG, nuclear grains; CG, cytoplasmic grains, NNG, net nuclear grains; *, mean per group (3 animals) with standard deviation
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
